Analyses of prognostic indices of chronic liver failure caused by hepatitis virus

Table 1 Comparison of laboratory indices of the two groups (mean±SD).

Items	Ineffective group	Effective group	Value of P
Glutamate-pyruvate transaminase (ALT)	196.70±291.74 U/L	215.54±349.53 U/L	>0.05
Glutamic-oxalacetic transaminase (AST)	214.05±234.75 U/L	207.93±233.69 U/L	>0.05
Alkaline phosphatase (ALP)	137.42±74.60 U/L	150.61±44.94 U/L	>0.05
Total bilirubin (Tbil)	612.332±195.943 µmol/L	506.624±184.454 µmol/L	<0.05
Direct bilirubin (Dbil)	356.837±119.196 µmol/L	306.827±112.52 µmol/L	<0.05
Serum albumin (ALB)	32.80±6.04 g/L	35.17±5.46 g/L	<0.05
Cholesterol (CHOL)	1.601±3.146 mmol/L	1.721±0.884 mmol/L	>0.05
Cholinesterase (CHE)	3453.69±1820.24 U/L	3198.16±1794.42 U/L	>0.05
Blood glucose (GLU)	4.609±3.932 mmol/L	4.650±2.303 mmol/L	>0.05
Blood urea nitrogen (BUN)	10.33±13.72 mmol/L	4.87±3.60 mmol/L	<0.05
Creatinine (Cr)	159.26±170.88 mmol/L	85.37±37.71 mmol/L	<0.05
Alpha fetoprotein (AFP)	111.46±177.53 ng/mL	170.45±230.25 ng/L	<0.05
Blood ammonia (NH3)	101.80±54.03 µmol/L	75.23±38.71 µmol/L	<0.05
Prothrombin time (PT)	35.63±14.37 s	27.14±11.04 s	<0.01
Prothrombin activity (PTA)	23.44±9.36%	32.56±9.51%	<0.01

Table 2 Comparison of complication distribution of two groups.

Items	Ineffective group, n (%)	Effective group, n (%)	P
Alimentary tract hemorrhage	39 (19.8)	4 (3.3)	<0.01
Hepatorenal syndrome	53 (26.9)	3 (2.4)	<0.01
Primary peritonitis	130 (66.0)	47 (38.2)	<0.01
Hepatic encephalopathy	136 (69.0)	17 (13.8)	<0.01
Infection of biliary tract	117 (59.4)	64 (52.0)	>0.05
Pulmonary infection	34 (17.1)	5 (4.1)	<0.01

Table 3 Comparison of B-ultrasonography of two groups.

Items	Ineffective group, n (%)	Effective group, n (%)	P
Liver shrinkage	105 (53.3)	39 (31.7)	<0.01
Enlarge of spleen	125 (63.5)	76 (61.8)	>0.05
Ascites	159 (80.7)	89 (72.4)	>0.05